JP2017529321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017529321A5 JP2017529321A5 JP2017504368A JP2017504368A JP2017529321A5 JP 2017529321 A5 JP2017529321 A5 JP 2017529321A5 JP 2017504368 A JP2017504368 A JP 2017504368A JP 2017504368 A JP2017504368 A JP 2017504368A JP 2017529321 A5 JP2017529321 A5 JP 2017529321A5
- Authority
- JP
- Japan
- Prior art keywords
- colitis
- disease
- inflammatory bowel
- composition
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462029875P | 2014-07-28 | 2014-07-28 | |
| US62/029,875 | 2014-07-28 | ||
| PCT/EP2015/067306 WO2016016262A1 (en) | 2014-07-28 | 2015-07-28 | Methods and compositions for diagnosing and treating inflammatory bowel disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017529321A JP2017529321A (ja) | 2017-10-05 |
| JP2017529321A5 true JP2017529321A5 (https=) | 2018-09-06 |
Family
ID=53762175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017504368A Withdrawn JP2017529321A (ja) | 2014-07-28 | 2015-07-28 | 炎症性腸疾患を診断ならびに処置するための方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20180113139A1 (https=) |
| EP (1) | EP3174895A1 (https=) |
| JP (1) | JP2017529321A (https=) |
| KR (1) | KR20170031245A (https=) |
| CN (1) | CN106573056A (https=) |
| AU (1) | AU2015295425A1 (https=) |
| BR (1) | BR112017001971A2 (https=) |
| CA (1) | CA2956683A1 (https=) |
| MA (1) | MA40406A (https=) |
| MX (1) | MX2017001293A (https=) |
| WO (1) | WO2016016262A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2627745T3 (es) | 2008-11-13 | 2017-07-31 | Nogra Pharma Limited | Composiciones antisentido, y procedimientos de fabricación y uso de las mismas |
| US20210369678A1 (en) * | 2018-10-03 | 2021-12-02 | Akebia Therapeutics, Inc. | Benzimidazole derivative for use in the treatment of inflammatory disorders |
| WO2021097131A1 (en) * | 2019-11-12 | 2021-05-20 | Orchard Therapeutics (Europe) Limited | Compositions and methods for treating or preventing crohn's disease |
| CN114729363A (zh) * | 2019-11-15 | 2022-07-08 | 诺格拉制药有限公司 | Il-34反义剂及其使用方法 |
| CA3159053A1 (en) | 2019-12-06 | 2021-06-10 | Sui Yi Kwok | Method of treating inflammatory bowel disease |
| AR121898A1 (es) | 2020-04-30 | 2022-07-20 | Lilly Co Eli | Compuestos y métodos dirigidos a interleucina-34 |
| AU2022276078A1 (en) | 2021-05-17 | 2024-01-04 | Nogra Pharma Limited | Il-34 antisense agents and methods of using same |
| AR127484A1 (es) | 2021-10-29 | 2024-01-31 | Lilly Co Eli | Compuestos y métodos dirigidos a interleucina-34 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8080246B2 (en) * | 2008-11-26 | 2011-12-20 | Five Prime Therapeutics, Inc. | Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules |
| RU2014136332A (ru) * | 2012-02-06 | 2016-03-27 | Дженентек, Инк. | Композиции и способы применения ингибиторов csf1r |
| CN107759690A (zh) * | 2012-08-31 | 2018-03-06 | 戊瑞治疗有限公司 | 用结合群落刺激因子1受体(csf1r)的抗体治疗病状的方法 |
-
2015
- 2015-07-28 MX MX2017001293A patent/MX2017001293A/es unknown
- 2015-07-28 CN CN201580041895.6A patent/CN106573056A/zh not_active Withdrawn
- 2015-07-28 JP JP2017504368A patent/JP2017529321A/ja not_active Withdrawn
- 2015-07-28 BR BR112017001971A patent/BR112017001971A2/pt not_active Application Discontinuation
- 2015-07-28 MA MA040406A patent/MA40406A/fr unknown
- 2015-07-28 AU AU2015295425A patent/AU2015295425A1/en not_active Abandoned
- 2015-07-28 WO PCT/EP2015/067306 patent/WO2016016262A1/en not_active Ceased
- 2015-07-28 CA CA2956683A patent/CA2956683A1/en not_active Abandoned
- 2015-07-28 KR KR1020177005114A patent/KR20170031245A/ko not_active Withdrawn
- 2015-07-28 EP EP15744550.3A patent/EP3174895A1/en not_active Withdrawn
- 2015-07-28 US US15/329,514 patent/US20180113139A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017529321A5 (https=) | ||
| Adar et al. | From airway inflammation to inflammatory bowel disease: eotaxin-1, a key regulator of intestinal inflammation | |
| Spiering et al. | Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model | |
| JP2010530852A (ja) | Ｉｌ−２０に関連する炎症性疾患を治療することにおける抗ｉｌ−２０抗体およびその使用 | |
| Sanders et al. | Epigenetic regulation of caveolin-1 gene expression in lung fibroblasts | |
| Donkervoort et al. | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability | |
| JP2006518991A5 (https=) | ||
| JP6721189B2 (ja) | ｖＷＦに結合するＤＮＡアプタマー | |
| BR112020007139A2 (pt) | tratamento de doença mediada por smc | |
| US20190160067A1 (en) | Anti-htlv-1 drug and therapeutic agent for htlv-1-associated myelopathy/tropical spastic paraparesis (ham/tsp) | |
| CN115068612A (zh) | Drd2抑制剂在制备治疗与肝脏纤维化有关的疾病的药物中的应用 | |
| CN110464844B (zh) | Alox12抑制剂在制备心脏缺血再灌注损伤治疗药物中的应用 | |
| Choi et al. | Productive infection of dendritic cells by simian immunodeficiency virus in macaque intestinal tissues | |
| KR20230088634A (ko) | 간암 특이적 바이오 마커 및 이의 용도 | |
| CN107326067A (zh) | 一种非酒精性脂肪肝的miRNA标记物 | |
| Zheng et al. | Treponema pallidum recombinant protein Tp47 activates NOD-like receptor family protein 3 inflammasomes in macrophages via glycolysis | |
| Wang et al. | The expression research of miR-210 in the elderly patients with COPD combined with ischemic stroke. | |
| JP6049143B2 (ja) | オリゴヌクレオチド、グルココルチコイド感受性増強剤、医薬組成物、及び発現ベクター | |
| JP2021505634A5 (https=) | ||
| WO2016079321A1 (en) | Antagonists of setdb2 for use in the therapy of infectious diseases | |
| JP6986263B2 (ja) | 抗ウイルス薬 | |
| IL296522A (en) | Compounds for treating or preventing a coronaviridae infection and methods and uses for assessing the occurrence of a coronaviridae infection | |
| JP4660376B2 (ja) | 血管障害や高血圧症の治療・予防剤、及びそのスクリーニング方法 | |
| CN109097358B (zh) | 一种lncRNA在预防或治疗高血压中的应用 | |
| US20250297310A1 (en) | Hematopoietic loss of y chromosome leads to cardiac fibrosis and dysfunction and is associated with death due to heart failure |